{{Short description|Organic compound}}
{{distinguish|uronic acid|urea}}
{{Use dmy dates|date=February 2020}}
{{Chembox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 476995734
| ImageFileL1 = Harnsäure_Ketoform.svg
| ImageFileL1_Ref = {{chemboximage|correct|??}}
| ImageFileR1 = Uric_acid3D.png
| ImageFileR1_Ref = {{chemboximage|correct|??}}
| ImageFile2 = Fluorescent uric acid.JPG
| ImageCaption2 = Crystals of urate in polarized light
| ImageSize2 = 180px
| PIN = 7,9-Dihydro-1''H''-purine-2,6,8(3''H'')-trione
| OtherNames = 2,6,8-Trioxypurine; 2,6,8-Trihydroxypurine; 2,6,8-Trioxopurine; 1''H''-Purine-2,6,8-trione
|Section1={{Chembox Identifiers
| IUPHAR_ligand = 4731
| CASNo = 69-93-2
| CASNo_Ref = {{cascite|correct|CAS}}
| PubChem = 1175
| ChemSpiderID = 1142
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| UNII = 268B43MJ25
| UNII_Ref = {{fdacite|correct|FDA}}
| EINECS = 200-720-7
| DrugBank = DB01696
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| KEGG = C00366
| KEGG_Ref = {{keggcite|changed|kegg}}
| MeSHName = Uric+Acid
| ChEBI = 27226
| ChEBI_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 792
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| SMILES = O=C1Nc2nc(=O)nc2C(=O)N1
| SMILES_Comment = [[lactam]] form
| SMILES1 = Oc0nc(O)nc1c0NC(=O)N1
| SMILES1_Comment = intermediate form
| SMILES2 = Oc0nc(O)nc1c0N=C(O)N1
| SMILES2_Comment = [[lactim]] form
| SMILES3 = Oc0nc(O)nc1c0N=C([O-])N1
| SMILES3_Comment = urate monoanion
| Beilstein = 156158
| 3DMet = B00094
| StdInChI = 1S/C5H4N4O3/c10-3-1-2(7-4(11)6-1)8-5(12)9-3/h5,12H,(H,9,10)(H,7,8,11)
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = DZGSAURIFGGOJK-UHFFFAOYSA-N
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
}}
|Section2={{Chembox Properties
| C=5 | H=4 | N=4 | O=3
| Appearance = White crystals
| Solubility = 6&nbsp;mg/100 mL (at 20&nbsp;°C)
| MeltingPtC = 300
| LogP = −1.107
| pKa = 5.6
| pKb = 8.4
| MagSus = {{val|-6.62|e=-5|u=cm<sup>3</sup> mol<sup>−1</sup>}}
}}
|Section3={{Chembox Thermochemistry
| DeltaHf = −619.69 to −617.93&nbsp;kJ&nbsp;mol<sup>−1</sup>
| DeltaHc = −1921.2 to −1919.56&nbsp;kJ&nbsp;mol<sup>−1</sup>
| Entropy = 173.2&nbsp;J&nbsp;K<sup>−1</sup>&nbsp;mol<sup>−1</sup>
| HeatCapacity = 166.15&nbsp;J&nbsp;K<sup>−1</sup>&nbsp;mol<sup>−1</sup> (at 24.0&nbsp;°C)
}} }}

'''Uric acid''' is a [[heterocyclic compound]] of [[carbon]], [[nitrogen]], [[oxygen]], and [[hydrogen]] with the [[Chemical formula|formula]] C<sub>5</sub>H<sub>4</sub>N<sub>4</sub>O<sub>3</sub>. It forms ions and salts known as '''urates''' and '''acid urates''', such as ammonium acid urate. Uric acid is a product of the metabolic breakdown of [[purine]] [[nucleotide]]s, and it is a normal component of [[urine]]. [[Hyperuricemia|High blood concentrations of uric acid]] can lead to [[gout]] and are associated with other medical conditions, including [[diabetes]] and the formation of ammonium acid urate [[kidney stones]].

==Chemistry==
Uric acid was first isolated from [[kidney stone]]s in 1776 by Swedish chemist [[Carl Wilhelm Scheele]].<ref name="Scheele">{{cite journal|author-link=Carl Wilhelm Scheele|last=Scheele|first=C. W.|title=Examen Chemicum Calculi Urinari|trans-title=A chemical examiniation of kidney stones|journal=Opuscula|date=1776|volume=2|page=73}}</ref> In 1882, the Ukrainian chemist [[Ivan Horbaczewski]] first synthesized uric acid by melting [[urea]] with [[glycine]].<ref>{{cite journal|first=J.|last=Horbaczewski|date=1882|url=https://books.google.com/books?id=b448AAAAIAAJ&pg=PA796|title=Synthese der Harnsäure|trans-title=Synthesis of uric acid|journal=Monatshefte für Chemie und Verwandte Teile Anderer Wissenschaften|volume=3|pages=796–797|doi=10.1007/BF01516847|s2cid=92323943}}</ref>

Uric acid displays lactam–lactim [[tautomerism]].<ref name="LiebermanMarks2007">{{cite book|last1=Lieberman|first1=M.|url=https://archive.org/details/marksessentialme0000lieb|title=Marks' Essential Medical Biochemistry|last2=Marks|first2=A. D.|last3=Smith|first3=C. M.|last4=Marks|first4=D. B.|publisher=Lippincott Williams & Wilkins|year=2007|isbn=978-0-7817-9340-7|location=Philadelphia|pages=[https://archive.org/details/marksessentialme0000lieb/page/47 47]–|url-access=registration}}</ref> Uric acid crystallizes in the lactam form,<ref>{{cite journal |last1=Ringertz |first1=H. |title=The molecular and crystal structure of uric acid |journal=Acta Crystallographica |date=1 March 1966 |volume=20 |issue=3 |pages=397–403 |doi=10.1107/S0365110X66000914|doi-access=free |bibcode=1966AcCry..20..397R }}</ref> with [[computational chemistry]] also indicating that tautomer to be the most stable.<ref>{{cite journal |last1=Jiménez |first1=V. |last2=Alderete |first2=J. B. |title=Theoretical calculations on the tautomerism of uric acid in gas phase and aqueous solution |journal=Journal of Molecular Structure: THEOCHEM |date=November 2005 |volume=755 |issue=1–3 |pages=209–214 |doi=10.1016/j.theochem.2005.08.001}}</ref>
Uric acid is a [[diprotic acid]] with [[pKa|p''K''<sub>a1</sub>]]&nbsp;=&nbsp;5.4 and p''K''<sub>a2</sub>&nbsp;=&nbsp;10.3.<ref>{{cite book|last=McCrudden|first=F. H.|title=Uric Acid: The Chemistry, Physiology and Pathology of Uric Acid and the Physiologically Important Purin Bodies, with a Discussion of the Metabolism in Gout|publisher=BiblioBazaar|year=2008|isbn=978-0-554-61991-0|location=Charleston, SC|orig-year=1905}}</ref> Thus at physiological pH, urate predominates in solution.

:{| cellpadding="5" border="0" style="text-align:center; float: center; background: transparent; border: 1px solid darkgray;"
|+ '''Tautomers of uric acid and urate'''
|-
|[[File:Harnsäure Ketoform.svg|130px]] || <br />[[File:Equilibrium2.svg|25px]] || [[file:Harnsäure Enolform.svg|150px]] || p''K''<sub>a1</sub><br />[[File:Equilibrium2.svg|25px]] || [[File:Urat.svg|150px]]
|-
| [[Lactam]] form || || [[Lactim]] form || || Urate ion
|}

===Water solubility===
In general, the water [[solubility]] of uric acid and its [[alkali metal]] and [[alkaline earth]] [[Salt (chemistry)|salts]] is rather low. All these salts exhibit greater solubility in hot water than cold, allowing for easy recrystallization. This low solubility is significant for the [[etiology]] of gout. The solubility of the acid and its salts in [[ethanol]] is very low or negligible. In ethanol/water mixtures, the solubilities are somewhere between the end values for pure ethanol and pure water.
:{| class="wikitable sortable"
|+ Solubility of urate salts (grams of water per gram of compound)
! data-sort-type="text" | Compound
! data-sort-type="number" | Cold water
! data-sort-type="number" | Boiling water
|-
| Uric acid
| align=right | 15,000
| align=right | 2,000
|-
| Ammonium hydrogen urate
| align=center | —
| align=right | 1,600
|-
| Lithium hydrogen urate
| align=right | 370
| align=right | 39
|-
| Sodium hydrogen urate
| align=right | 1,175
| align=right | 124
|-
| Potassium hydrogen urate
| align=right | 790
| align=right | 75
|-
| Magnesium dihydrogen diurate
| align=right | 3,750
| align=right | 160
|-
| Calcium dihydrogen diurate
| align=right | 603
| align=right | 276
|-
| Disodium urate
| align=right | 77
| align=center | —
|-
| Dipotassium urate
| align=right | 44
| align=right | 35
|-
| Calcium urate
| align=right | 1,500
| align=right | 1,440
|-
| Strontium urate
| align=right | 4,300
| align=right | 1,790
|-
| Barium urate
| align=right | 7,900
| align=right | 2,700
|}

The figures given indicate what mass of water is required to dissolve a unit mass of compound indicated. The lower the number, the more soluble the substance in the said solvent.<ref>{{cite book|title=CRC Handbook of Chemistry and Physics|title-link=CRC Handbook of Chemistry and Physics|publisher=[[CRC Press]]|year=1981|editor-last=Weast|editor-first=R. C.|edition=62nd|location=Boca Raton, FL|oclc=7842683}}</ref><ref>{{cite book|title=Merck Index|publisher=Merck|year=1976|isbn=978-0-911910-26-1|editor-last=Windholz|editor-first=M.|edition=9th}}</ref><ref>{{cite book | title = Uric acid | first = Francis H. | last = McCrudden | page = 58}}</ref>

==Biochemistry==
The enzyme [[xanthine oxidase]] (XO) [[catalysis|catalyzes]] the formation of uric acid from [[xanthine]] and [[hypoxanthine]]. XO, which is found in mammals, functions primarily as a dehydrogenase and rarely as an oxidase, despite its name.<ref>{{Cite journal|first1=K. |last1=Ichida |first2=Y. |last2=Amaya |first3=K. |last3=Noda |first4=S. |last4=Minoshima |first5=T. |last5=Hosoya |first6=O. |last6=Sakai |first7=N. |last7=Shimizu |first8=T. |last8=Nishino |date=November 1993|title=Cloning of the cDNA encoding human xanthine dehydrogenase (oxidase): Structural analysis of the protein and chromosomal location of the gene|url=https://linkinghub.elsevier.com/retrieve/pii/037811199390652J|journal=Gene|language=en|volume=133|issue=2|pages=279–284|doi=10.1016/0378-1119(93)90652-J|pmid=8224915}}</ref>) Xanthine in turn is produced from other [[purine]]s. Xanthine oxidase is a large enzyme whose [[active site]] consists of the metal [[molybdenum]] bound to [[sulfur]] and oxygen.<ref name="Hille">{{cite journal | pmid = 15581570 | year = 2005 | last1 = Hille | first1 = R. | title = Molybdenum-containing hydroxylases | volume = 433 | issue = 1 | pages = 107–116 | doi = 10.1016/j.abb.2004.08.012 | journal = Archives of Biochemistry and Biophysics}}</ref> <!--tangential: Within cells, xanthine oxidase can exist as xanthine dehydrogenase and xanthine oxireductase, which has also been purified from [[Bovinae|bovine]] milk and [[spleen]] extracts.<ref name="Hori">{{cite journal |last1=Hori |first1=N. |last2=Uehara |first2=K. |last3=Mikami |first3=Y. | journal = Bioscience, Biotechnology, and Biochemistry | year = 1992 | volume = 56 | pages = 580–582 | doi = 10.1271/bbb.56.580 |pmid=27280651 | title = Enzymatic Synthesis of 5-Methyluridine from Adenosine and Thymine with High Efficiency | issue = 4|doi-access=free }}</ref>--> Uric acid is released in [[Hypoxia (medical)|hypoxic]] conditions (low oxygen saturation).<ref name="Baillie 1473-1478">{{Cite journal| volume = 131| issue = 5| pages = 1473–1478| last1 = Baillie| first1 = J. K. |first2=M. G. |last2=Bates |first3=A. A. |last3=Thompson |first4=W. S. |last4=Waring |first5=R. W. |last5=Partridge |first6=M. F. |last6=Schnopp |first7=A. |last7=Simpson |first8=F. |last8=Gulliver-Sloan |first9=S. R. |last9=Maxwell |first10=D. J. |last10=Webb | title = Endogenous urate production augments plasma antioxidant capacity in healthy lowland subjects exposed to high altitude| journal = Chest| date = May 2007| doi = 10.1378/chest.06-2235| pmid = 17494796}}</ref>

== Genetic and physiological diversity ==
=== Primates ===
In [[humans]] uric acid (actually hydrogen urate ion) is the final [[oxidation]] (breakdown) product of [[purine metabolism]] and is excreted in urine, whereas in most other [[mammal]]s, the enzyme [[uricase]] further oxidizes uric acid to [[allantoin]].<ref>{{cite web|last=Angstadt |first=C. N. |title=Purine and Pyrimidine Metabolism: Purine Catabolism |website=NetBiochem |date=4 December 1997 |url=http://library.med.utah.edu/NetBiochem/pupyr/pp.htm#Pu%20Catab}}</ref> The loss of uricase in higher primates parallels the similar loss of the ability to synthesize [[Vitamin C|ascorbic acid]], leading to the suggestion that urate may partially substitute for ascorbate in such species.<ref name="Proct">{{cite journal |last=Proctor |first=P. |title=Similar functions of uric acid and ascorbate in man? |journal=Nature |volume=228 |issue=5274 |pages=868 |date=November 1970 |pmid=5477017 |doi= 10.1038/228868a0|bibcode=1970Natur.228..868P |s2cid=4146946 |doi-access=free }}</ref> Both uric acid and ascorbic acid are strong [[reducing agent]]s ([[electron donor]]s) and potent [[antioxidant]]s. In humans, over half the antioxidant capacity of [[blood plasma]] comes from hydrogen urate ion.<ref>{{cite journal | doi = 10.1046/j.1365-2362.1997.1390687.x | title = Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus | year = 1997 | last1 = Maxwell | first1 = S. R. J. | last2 = Thomason | first2 = H. | last3 = Sandler | first3 = D. | last4 = Leguen | first4 = C. | last5 = Baxter | first5 = M. A. | last6 = Thorpe | first6 = G. H. G. | last7 = Jones | first7 = A. F. | last8 = Barnett | first8 = A. H. | journal = European Journal of Clinical Investigation | volume = 27 | issue = 6 | pages = 484–490 | pmid = 9229228| s2cid = 11773699 }}
</ref>

==== Humans ====
The normal concentration range of uric acid (or hydrogen urate ion) in human blood is 25 to 80&nbsp;mg/L for men and 15 to 60&nbsp;mg/L for women<ref>{{cite book|title=Harrison's Principles of Internal Medicine|publisher=[[McGraw-Hill Education|McGraw-Hill]]|year=1987|isbn=978-0-07-079454-2|editor-last=Braunwald|editor-first=E.|edition=11th|location=New York|page=A-3}}</ref> (but see below for slightly different values). An individual can have serum values as high as 96&nbsp;mg/L and not have gout.<ref name="hyperuricemia" /> In humans, about 70% of daily uric acid disposal occurs via the kidneys, and in 5–25% of humans, impaired renal (kidney) excretion leads to [[hyperuricemia]].<ref name="Vitart_2008">{{cite journal |last1=Vitart |first1=V. |last2=Rudan |first2=I. |last3=Hayward |first3=C. |display-authors=etal |title=SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout |journal=Nature Genetics |volume=40 |issue=4 |pages=437–442 |date=April 2008 |pmid=18327257 |doi=10.1038/ng.106 |s2cid=6720464 }}</ref> Normal excretion of uric acid in the urine is 270 to 360&nbsp;mg per day (concentration of 270 to 360&nbsp;mg/L if one litre of urine is produced per day – higher than the solubility of uric acid because it is in the form of dissolved acid urates), roughly 1% as much as the daily excretion of [[urea]].<ref>{{Cite book| url=https://www.ncbi.nlm.nih.gov/books/NBK562201/ | pmid=32965872 | title=StatPearls | chapter=Hyperuricosuria | year=2022 | publisher=StatPearls | last1=Kaur | first1=P. | last2=Bhatt | first2=H. }}</ref>

=== Dogs ===
The [[Dalmatian (dog)#Kidney and bladder stones|Dalmatian]] has a genetic defect in uric acid uptake by the [[liver]] and [[kidney]]s, resulting in decreased conversion to [[allantoin]], so this breed excretes uric acid, and not allantoin, in the urine.<ref>{{cite journal |last1=Friedman |first1=M. |last2=Byers |first2=S. O. |name-list-style=amp |title=Observations concerning the causes of the excess excretion of uric acid in the Dalmatian dog |journal=The Journal of Biological Chemistry |volume=175 |issue=2 |pages=727–735 |date=1 September 1948 |doi=10.1016/S0021-9258(18)57191-X |pmid=18880769 |doi-access=free }}</ref>

=== Birds, reptiles and desert-dwelling mammals ===
In [[bird]]s and [[reptile]]s, and in some desert-dwelling mammals (such as the [[kangaroo rat]]), uric acid also is the end product of purine metabolism, but it is excreted in [[feces]] as a dry mass. This involves a complex [[metabolic pathway]] that is energetically costly in comparison to processing of other nitrogenous wastes such as [[urea]] (from the [[urea cycle]]) or [[ammonia]], but has the advantages of reducing water loss and preventing dehydration.<ref name="Hazard">{{cite book | last = Hazard | first = L. C. | title = Sodium and Potassium Secretion by Iguana Salt Glands | series = Iguanas: Biology and Conservation | publisher = University of California Press | pages = 84–85 | year = 2004 | isbn = 978-0-520-23854-1 | url = https://books.google.com/books?id=Dyb8bNBh5nwC }}</ref>

=== Invertebrates ===
''[[Platynereis dumerilii]]'', a marine [[polychaete]] worm, uses uric acid as a sexual [[pheromone]]. The female of the species releases uric acid into the water during [[mating]], which induces males to release sperm.<ref>{{cite journal|last1=Zeeck|first1=E.|last2=Harder|first2=T.|last3=Beckmann|first3=M.|title= Uric acid: the sperm-release pheromone of the marine polychaete ''Platynereis dumerilii'' |journal=Journal of Chemical Ecology|date=1998|volume=24|issue=1|pages=13–22|doi=10.1023/A:1022328610423|s2cid=42318049}}</ref>

==Genetics==
Although foods such as meat and seafood can elevate serum urate levels, genetic variation is a much greater contributor to high serum urate.<ref name="pmid30305269">{{cite journal | last1=Major |first1=T. J. |last2=Topless |first2=R. K. |last3=Merriman |first3=T. R. | title=Evaluation of the diet wide contribution to serum urate levels: meta-analysis of population based cohorts | journal=[[The BMJ]] | volume=363 | pages=k3951 | year=2018 | doi = 10.1136/bmj.k3951 | pmc=6174725 | pmid=30305269}}</ref><ref name="pmid32620198">{{cite journal | author=Keenan |first=R. T. | title=The biology of urate | journal=Seminars in Arthritis and Rheumatism | volume=50 | issue=35| pages=S2–S10 | year=2020 | doi = 10.4103/bc.bc_1_19 | pmid=32620198| pmc=6611195 |doi-access=free }}</ref> A proportion of people have mutations in the urate transport proteins responsible for the excretion of uric acid by the kidneys. Variants of a number of genes, linked to serum urate, have so far been identified: ''[[SLC2A9]]''; ''[[ABCG2]]''; ''[[SLC17A1]]''; ''[[SLC22A11]]''; ''[[SLC22A12]]''; ''[[SLC16A9]]''; ''[[GCKR]]''; ''[[LRRC16A]]''; and ''[[PDZK1]]''.<ref>{{cite journal |last1=Aringer |first1=M. |last2=Graessler |first2=J. |title=Understanding deficient elimination of uric acid |journal=Lancet |volume=372 |issue=9654 |pages=1929–1930 |date=December 2008 |pmid=18834627 |doi=10.1016/S0140-6736(08)61344-6|s2cid=1839089 }}</ref><ref name="Kolz_2009">{{cite journal |last1=Kolz |first1=M. |last2=Johnson |first2=T. |display-authors=etal | editor1-last=Allison | editor1-first=David B. |title=Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations | journal=PLOS Genet. |date=June 2009 | volume=5 | issue=6 | pmid=19503597 | doi=10.1371/journal.pgen.1000504 | pages=e1000504 | pmc=2683940 |doi-access=free }}</ref><ref>{{cite journal|last=Köttgen|first=A.|title=Genome-wide association analyses identify 18 new loci associated with serum urate concentrations|journal=Nature Genetics|date=February 2013|volume=45|issue=2|pages=145–154|pmid=23263486|doi=10.1038/ng.2500|pmc=3663712|display-authors=etal|url=https://www.pure.ed.ac.uk/ws/files/8739767/Genome_wide_association_analyses_identify_18_new_loci_associated_with_serum_urate_concentrations.pdf}}</ref> GLUT9, encoded by the ''SLC2A9'' gene, is known to transport both uric acid and [[fructose]].<ref name="Vitart_2008"/><ref name="Döring_2008">{{cite journal |last1=Döring |first1=A. |last2=Gieger |first2=C. |last3=Mehta |first3=D. |display-authors=etal |title=SLC2A9 influences uric acid concentrations with pronounced sex-specific effects |journal=Nature Genetics |volume=40 |issue=4 |pages=430–436 |date=April 2008 |pmid=18327256 |doi=10.1038/ng.107|s2cid=29751482 }}</ref><ref>{{Cite journal|last1=Mandal|first1=Asim K.|last2=Mount|first2=David B.|date=February 2015|title=The molecular physiology of uric acid homeostasis|url=https://pubmed.ncbi.nlm.nih.gov/25422986/|journal=[[Annual Review of Physiology]]|volume=77|pages=323–345|doi=10.1146/annurev-physiol-021113-170343|pmid=25422986}}</ref>

Myogenic [[hyperuricemia]], as a result of the [[Purine nucleotide cycle|Purine Nucleotide Cycle]] running when ATP reservoirs in muscle cells are low, is a common pathophysiologic feature of [[Glycogen storage disease|glycogenoses]] such as [[Glycogen storage disease type III|GSD-III]], [[Glycogen storage disease type V|GSD-V]] and [[Glycogen storage disease type VII|GSD-VII]], as they are [[Metabolic myopathy|metabolic myopathies]] which impair the ability of ATP (energy) production for the muscle cells to use.<ref name=":0">{{cite journal | doi=10.1056/NEJM198707093170203 | title=Myogenic Hyperuricemia | year=1987 | last1=Mineo | first1=Ikuo | last2=Kono | first2=Norio | last3=Hara | first3=Naoko | last4=Shimizu | first4=Takao | last5=Yamada | first5=Yuya | last6=Kawachi | first6=Masanori | last7=Kiyokawa | first7=Hiroaki | last8=Wang | first8=Yan Lin | last9=Tarui | first9=Seiichiro | journal=New England Journal of Medicine | volume=317 | issue=2 | pages=75–80 | pmid=3473284 }}</ref> In these metabolic myopathies, myogenic hyperuricemia is exercise-induced; inosine, hypoxanthine and uric acid increase in plasma after exercise and decrease over hours with rest.<ref name=":0" /> Excess AMP (adenosine monophosphate) is converted into uric acid.

AMP → IMP → Inosine → Hypoxanthine → Xanthine → Uric Acid

==Clinical significance and research==
In human [[blood plasma]], the [[Reference ranges for blood tests#Other electrolytes and metabolites|reference range]] of uric acid is typically 3.4–7.2&nbsp;mg per 100&nbsp;mL(200–430&nbsp;μmol/L) for men, and 2.4–6.1&nbsp;mg per 100&nbsp;mL for women (140–360&nbsp;μmol/L).<ref>{{cite web|title=Harmonisation of Reference Intervals|url=http://www.acb.org.uk/docs/Pathology%20Harmony%20for%20web.pdf|website=Pathology Harmony (UK)|access-date=13 August 2013|url-status=dead|archive-url=https://web.archive.org/web/20130802082027/http://www.acb.org.uk/docs/Pathology%20Harmony%20for%20web.pdf|archive-date=2 August 2013}}</ref> Uric acid concentrations in blood plasma above and below the normal range are known as, respectively, [[hyperuricemia]] and [[hypouricemia]]. Likewise, uric acid concentrations in urine above and below normal are known as [[hyperuricosuria]] and [[hypouricosuria]]. Uric acid levels in saliva may be associated with blood uric acid levels.<ref>{{Cite journal|pmid=26276048|year=2015|last1=Zhao|first1=J|title=Salivary uric acid as a noninvasive biomarker for monitoring the efficacy of urate-lowering therapy in a patient with chronic gouty arthropathy|journal=Clinica Chimica Acta|volume=450|pages=115–20|last2=Huang|first2=Y|doi=10.1016/j.cca.2015.08.005}}</ref>

===High uric acid===
[[Hyperuricemia]] (high levels of uric acid), which induces [[gout]], has various potential origins:
* Diet may be a factor. High intake of dietary [[purine]], [[high-fructose corn syrup]], and [[table sugar|sucrose]] can increase levels of uric acid.<ref name="Cirillo">{{cite journal | pmid = 17130256 | doi=10.1681/ASN.2006080909 | volume=17 | issue=12 Suppl. 3 | title=Uric acid, the metabolic syndrome, and renal disease |date=December 2006 |last1=Cirillo |first1=P. |last2=Sato |first2=W. |last3=Reungjui |first3=S. |display-authors=etal | journal=Journal of the American Society of Nephrology | pages=S165–S168| s2cid=28722975 |url=http://jasn.asnjournals.org/content/17/12_suppl_3/S165.full.pdf }}</ref><ref name="Theodore">{{cite journal | pmid = 19403709 | doi=10.3945/jn.108.098194 | volume=139 | issue=6 | title=The Effect of High-Fructose Corn Syrup Consumption on Triglycerides and Uric Acid |date=June 2009 | first1=T. J. |last1=Angelopoulos |first2=J. |last2=Lowndes |first3=L. |last3=Zukley |first4=K. J. |last4=Melanson |first5=V. |last5=Nguyen |first6=A. |last6=Huffman |first7=J. M. |last7=Rippe | journal=The Journal of Nutrition | pages=1242S–1245S|doi-access=free }}</ref>
* Serum uric acid can be elevated by reduced excretion via the [[kidney]]s.<ref name="Mayo">{{cite web|<!--author=Mayo Clinic staff |-->date=11 September 2010 |url=http://www.mayoclinic.com/health/high-uric-acid-level/MY00160 |title=High uric acid level |website=Mayo Clinic |access-date=24 April 2011}}</ref>
* Fasting or rapid weight loss can temporarily elevate uric acid levels.<ref name="pmid7024153">{{cite journal| last = Howard | first = A. N. | title = The historical development, efficacy and safety of very-low-calorie diets| journal = International Journal of Obesity| volume = 5| issue = 3| pages = 195–208| year = 1981| pmid = 7024153}}</ref>
* Certain drugs, such as [[thiazide]] diuretics, can increase blood uric acid levels by interfering with [[Clearance (medicine)|renal clearance]].<ref>{{cite web|title=Diuretic-Related Side Effects: Development and Treatment|url=http://www.medscape.com/viewarticle/489521_7|publisher=Medscape|access-date=17 May 2013}}</ref>
* [[Tumor lysis syndrome]], a metabolic complication of certain cancers or chemotherapy, due to [[nucleobase]] and potassium release into the plasma.<ref name="howard"/>
* [[Pseudohypoxia]] (disrupted NADH/NAD<sup>+</sup> ratio) caused by diabetic hyperglycemia and excessive alcohol consumption.<ref>{{Cite book |last=Coffee |first=Carole J. |title=Quick Look Medicine: Metabolism |publisher=Hayes Barton Press |year=1999 |isbn=1-59377-192-4 |pages=176–177}}</ref>

====Gout====
{{main|Gout}}
A 2011 survey in the United States indicated that 3.9% of the population had gout, whereas 21.4% had hyperuricemia without having symptoms.<ref name="pmid30485934">{{cite journal | last1=Li |first1=R. |last2=Yu |first2=K. |last3=Li |first3=C. | title=Dietary factors and risk of gout and hyperuricemia: a meta-analysis and systematic review | journal=Asia Pacific Journal of Clinical Nutrition | volume=27 | issue=6 | pages=1344–1356 | year=2018 | doi = 10.6133/apjcn.201811_27(6).0022 | pmid=30485934}}</ref>

Excess blood uric acid (serum urate) can induce [[gout]],<ref name="Heinig M, Johnson RJ 2006 1059–64">{{cite journal |last1=Heinig |first1=M. |last2=Johnson |first2=R. J. |title=Role of uric acid in hypertension, renal disease, and metabolic syndrome |journal=Cleveland Clinic Journal of Medicine |volume=73 |issue=12 |pages=1059–1064 |date=December 2006 |pmid=17190309 |doi=10.3949/ccjm.73.12.1059|s2cid=45409308 }}</ref> a painful condition resulting from needle-like crystals of uric acid termed ''monosodium urate crystals''<ref name="Abhishek">{{cite journal |last1=Abhishek |first1=A |last2=Roddy |first2=E |last3=Doherty |first3=M |title=Gout - a guide for the general and acute physicians. |journal=Clinical Medicine |date=February 2017 |volume=17 |issue=1 |pages=54–59 |doi=10.7861/clinmedicine.17-1-54 |pmid=28148582|pmc=6297580 }}</ref> precipitating in [[joint]]s, [[Capillary|capillaries]], [[skin]], and other tissues.<ref name=Lancet2010>{{cite journal |last1=Richette |first1=P. |last2=Bardin |first2=T. |title=Gout |journal=Lancet |volume=375 |issue=9711 |pages=318–328 |date=January 2010 |pmid=19692116 |doi=10.1016/S0140-6736(09)60883-7 |s2cid=208793280 }}</ref> Gout can occur where serum uric acid levels are as low as 6&nbsp;mg per 100&nbsp;mL (357&nbsp;μmol/L), but an individual can have serum values as high as 9.6&nbsp;mg per 100&nbsp;mL (565&nbsp;μmol/L) and not have gout.<ref name=hyperuricemia>{{cite journal |last1=Tausche |first1=A. K. |last2=Unger |first2=S. |last3=Richter |first3=K. |display-authors=etal |trans-title=Hyperuricemia and gout: diagnosis and therapy |language=de |journal=Der Internist |volume=47 |issue=5 |pages=509–521 |date=May 2006 |pmid=16586130 |doi=10.1007/s00108-006-1578-y |title=Hyperurikämie und Gicht|s2cid=11480796 }}</ref>

In humans, purines are metabolized into uric acid, which is then excreted in the urine. Consumption of large amounts of some types of purine-rich foods, particularly meat and seafood, increases gout risk.<ref name=Choi>{{cite journal |last1=Choi |first1=H. K. |last2=Atkinson |first2=K. |last3=Karlson |first3=E. W. |last4=Willett |first4=W. |last5=Curhan |first5=G. |title=Purine-rich foods, dairy and protein intake, and the risk of gout in men |journal=The New England Journal of Medicine |volume=350 |issue=11 |pages=1093–1103 |date=March 2004 |pmid=15014182 |doi=10.1056/NEJMoa035700|doi-access=free }}</ref> Purine-rich foods include liver, kidney, and sweetbreads, and certain types of seafood, including anchovies, herring, sardines, mussels, scallops, trout, haddock, mackerel, and tuna.<ref>{{Cite web|date=July 2, 2020|title=Gout diet: What's allowed, what's not|url=http://www.mayoclinic.org/healthy-lifestyle/nutrition-and-healthy-eating/in-depth/gout-diet/art-20048524|website=[[Mayo Clinic]]|publisher=}}</ref> Moderate intake of purine-rich vegetables, however, is not associated with an increased risk of gout.<ref name=Choi/>

One treatment for gout in the 19th century was administration of [[lithium]] salts;<ref>{{cite journal |first= Gerhard N. |last=Schrauzer |journal=Journal of the American College of Nutrition |volume=21 |issue=1 |pages=14–21 |year=2002 |title= Lithium: Occurrence, Dietary Intakes, Nutritional Essentiality |pmid= 11838882 |doi= 10.1080/07315724.2002.10719188|s2cid=25752882 }}</ref> lithium urate is more soluble. Today, inflammation during attacks is more commonly treated with [[NSAID]]s, [[colchicine]], or [[corticosteroid]]s, and urate levels are managed with [[allopurinol]].<ref>{{cite web|title=NHS Clinical Knowledge Summaries |url=http://www.cks.nhs.uk/gout/background_information/causes_and_risk_factors#-291124 |url-status=dead |archive-url=https://web.archive.org/web/20120304060453/http://www.cks.nhs.uk/gout/background_information/causes_and_risk_factors |archive-date=4 March 2012 |publisher=UK [[National Health Service]]}}</ref> Allopurinol, which weakly inhibits xanthine oxidase, is an analog of hypoxanthine that is hydroxylated by [[Xanthine oxidase|xanthine oxidoreductase]] at the 2-position to give oxipurinol.<ref>{{cite journal|pmid=16507884|pmc=2233605|year=2006|last1=Pacher|first1=P.|title=Therapeutic effects of xanthine oxidase inhibitors: Renaissance half a century after the discovery of allopurinol|journal=Pharmacological Reviews|volume=58|issue=1|pages=87–114|last2=Nivorozhkin|first2=A.|last3=Szabó|first3=C.|doi=10.1124/pr.58.1.6}}</ref>

====Tumor lysis syndrome====
[[Tumor lysis syndrome]], an emergency condition that may result from [[blood cancer]]s, produces high uric acid levels in blood when tumor cells release their contents into the blood, either spontaneously or following [[chemotherapy]].<ref name="howard">{{Cite journal|last1=Howard|first1=S. C.|last2=Jones|first2=D. P.|last3=Pui|first3=C.-H.|date=12 May 2011|title=The Tumor Lysis Syndrome|journal=The New England Journal of Medicine|volume=364|issue=19|pages=1844–1854|doi=10.1056/NEJMra0904569|issn=0028-4793|pmc=3437249|pmid=21561350}}</ref> Tumor lysis syndrome may lead to [[acute kidney injury]] when uric acid crystals are deposited in the kidneys.<ref name=howard/> Treatment includes&nbsp;[[hyperhydration]] to dilute and excrete uric acid via [[urine]], [[rasburicase]] to reduce levels of poorly soluble uric acid in blood, or&nbsp;[[allopurinol]] to inhibit [[purine]] [[catabolism]] from adding to uric acid levels.<ref name=howard/>

====Lesch–Nyhan syndrome====
[[Lesch–Nyhan syndrome]], a rare inherited disorder, is also associated with high serum uric acid levels.<ref>{{cite journal |last1=Luo |first1=Y. C. |last2=Do |first2=J. S. |last3=Liu |first3=C. C. |title=An amperometric uric acid biosensor based on modified Ir–C electrode |journal=Biosensors & Bioelectronics |volume=22 |issue=4 |pages=482–488 |date=October 2006 |pmid=16908130 |doi=10.1016/j.bios.2006.07.013}}</ref> Spasticity, involuntary movement, and cognitive retardation as well as manifestations of gout are seen in this syndrome.<ref>{{cite journal |last=Nyhan |first=W. L. |title=Lesch-Nyhan Disease |journal=Journal of the History of the Neurosciences |volume=14 |issue=1 |pages=1–10 |date=March 2005 |pmid=15804753 |doi=10.1080/096470490512490|s2cid=37934468 }}</ref>

====Cardiovascular disease====
Hyperuricemia is associated with an increase in [[risk factors]] for [[cardiovascular disease]].<ref>{{cite journal|journal=Expert Review of Cardiovascular Therapy |year=2014 |volume=12 |issue=10 |pages=1219–1225 |doi=10.1586/14779072.2014.957675 |pmid=25192804|title=Hyperuricemia and cardiovascular disease risk |last1=Borghi |first1=C. |last2=Verardi |first2=F. M. |last3=Pareo |first3=I. |last4=Bentivenga |first4=C. |last5=Cicero |first5=A. F.|s2cid=42023170 }}</ref> It is also possible that high levels of uric acid may have a causal role in the development of atherosclerotic cardiovascular disease, but this is controversial and the data are conflicting.<ref>{{Cite journal |last1=Saito |first1=Yuichi |last2=Tanaka |first2=Atsushi |last3=Node |first3=Koichi |last4=Kobayashi |first4=Yoshio |date=July 2021 |title=Uric acid and cardiovascular disease: A clinical review |journal=Journal of Cardiology |volume=78 |issue=1 |pages=51–57 |doi=10.1016/j.jjcc.2020.12.013 |issn=1876-4738 |pmid=33388217|s2cid=230482803 |doi-access=free }}</ref>

====Uric acid stone formation====
[[File:Urine crystals comparison.png|thumb|Comparison of different types of urinary crystals.]]
[[Kidney stone]]s can form through deposits of sodium urate microcrystals.<ref name="Banach">{{cite journal |last1=Banach |first1=K. |last2=Bojarska |first2=E. |last3=Kazimierczuk |first3=Z. |last4=Magnowska |first4=L. |last5=Bzowska |first5=A. |date=2005 |title=Kinetic Model of Oxidation Catalyzed by Xanthine Oxidase—The Final Enzyme in Degradation of Purine Nucleosides and Nucleotides |journal=Nucleic Acids |volume=24 |issue=5–7 |pages=465–469 |doi=10.1081/ncn-200060006 |pmid=16247972 |s2cid=42906456}}</ref>

Saturation levels of uric acid in blood may result in one form of [[kidney stone]]s when the urate crystallizes in the kidney. These uric acid stones are [[radiodensity|radiolucent]], so do not appear on an abdominal plain [[X-ray]].<ref>{{Cite journal |last1=Worcester |first1=E. M. |last2=Coe |first2=F. L. |date=2008 |title=Nephrolithiasis |journal=Primary Care: Clinics in Office Practice |language=en |volume=35 |issue=2 |pages=369–391 |doi=10.1016/j.pop.2008.01.005 |pmc=2518455 |pmid=18486720}}</ref> Uric acid crystals can also promote the formation of [[calcium oxalate]] stones, acting as "seed crystals".<ref>{{cite journal |last=Pak |first=C. Y. |date=September 2008 |title=Medical stone management: 35 years of advances |journal=The Journal of Urology |volume=180 |issue=3 |pages=813–819 |doi=10.1016/j.juro.2008.05.048 |pmid=18635234}}</ref>

====Diabetes====
Hyperuricemia is associated with components of [[metabolic syndrome]], including in children.<ref>{{Cite journal|last=De Oliveira|first=E. P. |display-authors=etal |date=2012|title=High plasma uric acid concentration: Causes and consequences|journal=Diabetology & Metabolic Syndrome|volume=4|pages=12|pmid=22475652|pmc=3359272|doi=10.1186/1758-5996-4-12 |doi-access=free }}</ref><ref>{{Cite journal|last=Wang|first=J. Y.|display-authors=etal|date=2012|title=Predictive value of serum uric acid levels for the diagnosis of metabolic syndrome in adolescents|journal=The Journal of Pediatrics|volume=161 |issue=4|pages=753–6.e2|pmid=22575243|doi=10.1016/j.jpeds.2012.03.036}}</ref>

===Low uric acid===
Low uric acid ([[hypouricemia]]) can have numerous causes. Low dietary [[zinc]] intakes cause lower uric acid levels. This effect can be even more pronounced in women taking oral contraceptive medication.<ref>{{cite journal |last1=Hess |first1=F. M. |last2=King |first2=J. C. |last3=Margen |first3=S. |title=Effect of low zinc intake and oral contraceptive agents on nitrogen utilization and clinical findings in young women |journal=The Journal of Nutrition |volume=107 |issue=12 |pages=2219–2227 |date=1 December 1977|pmid=925768 |doi=10.1093/jn/107.12.2219}}</ref> [[Sevelamer]], a drug indicated for prevention of [[hyperphosphataemia]] in people with [[chronic kidney failure]], can significantly reduce serum uric acid.<ref>{{cite journal |last1=Garg |first1=J. P. |last2=Chasan-Taber |first2=S. |last3=Blair |first3=A. |display-authors=etal |title=Effects of sevelamer and calcium-based phosphate binders on uric acid concentrations in patients undergoing hemodialysis: a randomized clinical trial |journal=Arthritis and Rheumatism |volume=52 |issue=1 |pages=290–295 |date=January 2005 |pmid=15641045 |doi=10.1002/art.20781|doi-access=free }}</ref>

====Multiple sclerosis====
[[Meta-analysis]] of 10 case-control studies found that the serum uric acid levels of patients with [[multiple sclerosis]] were significantly lower compared to those of healthy controls, possibly indicating a diagnostic [[biomarker]] for multiple sclerosis.<ref>{{cite journal |last1=Wang |first1=L. |last2=Hu |first2=W. |last3=Wang |first3=J. |last4=Qian |first4=W. |last5=Xiao |first5=H. |year=2016 |title=Low serum uric acid levels in patients with multiple sclerosis and neuromyelitis optica: An updated meta-analysis |pmid=27645338 |journal=Multiple Sclerosis and Related Disorders |volume=9 |pages=17–22 |doi=10.1016/j.msard.2016.05.008}}</ref>

====Normalizing low uric acid====
Correcting low or deficient zinc levels can help elevate [[blood serum|serum]] uric acid.<ref>{{cite journal |last1=Umeki |first1=S. |last2=Ohga |first2=R. |last3=Konishi |first3=Y. |last4=Yasuda |first4=T. |last5=Morimoto |first5=K. |last6=Terao |first6=A. |title=Oral zinc therapy normalizes serum uric acid level in Wilson's disease patients |journal=The American Journal of the Medical Sciences |volume=292 |issue=5 |pages=289–292 |date=November 1986 |pmid=3777013 |doi=10.1097/00000441-198611000-00007|s2cid=39995735 |doi-access=free }}</ref>

== See also ==
* [[Theacrine]] or 1,3,7,9-tetramethyluric acid, a purine alkaloid found in some teas
* [[Uracil]] – [[purine]] [[nucleobase]] named by Robert Behrend who was attempting to synthesize derivatives of uric acid
* [[Metabolic myopathy]]
* [[Purine nucleotide cycle]]

==References==
{{Reflist|30em}}

==External links==
{{Commons category}}
* [https://www.nlm.nih.gov/medlineplus/ency/article/003476.htm Uric acid blood test – MedlinePlus]

{{Nucleotide metabolism intermediates}}
{{Antioxidants}}
{{Purinergics}}

{{Authority control}}

{{DEFAULTSORT:Uric Acid}}
[[Category:Uric acid| ]]
[[Category:Nitrogen cycle]]
[[Category:Organic acids]]
[[Category:Triketones]]